Sheel Biotech (NSE:SHEEL) Total Assets: ₹1,458 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHEEL Sheel Biotech Ltd NSE:SHEEL
18 GF Score
Price ₹68.00
! 2 Warning Signs
View Full Analysis

What is Sheel Biotech Total Assets?

Sheel Biotech NSE:SHEEL 18 Total Assets is ₹1,458 Mil as of Mar. 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Sheel Biotech's Total Assets for the quarter that ended in Mar. 2026 was ₹1,458 Mil.

During the past 12 months, Sheel Biotech's average Total Assets Growth Rate was 27.30% per year. During the past 3 years, the average Total Assets Growth Rate was 15.30% per year.

During the past 5 years, Sheel Biotech's highest 3-Year average Total Assets Growth Rate was 15.30%. The lowest was 6.70%. And the median was 11.00%.

Total Assets is connected with ROA %. Sheel Biotech's annualized ROA % for the quarter that ended in Mar. 2026 was 9.08%. Total Assets is also linked to Revenue through Asset Turnover. Sheel Biotech's Asset Turnover for the quarter that ended in Mar. 2026 was 0.85.


Sheel Biotech  (NSE:SHEEL) Total Assets Explanation

Total Assets is connected with ROA %.

Sheel Biotech's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=117.564/( (1132.826+1457.843)/ 2 )
=117.564/1295.3345
=9.08 %

Note: The Net Income data used here is one times the annual (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sheel Biotech's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=1100.224/( (1132.826+1457.843)/ 2 )
=1100.224/1295.3345
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sheel Biotech Total Assets Related Terms


Sheel Biotech Total Assets Historical Data

* Premium members only.

The historical data trend for Sheel Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sheel Biotech Total Assets Chart

Sheel Biotech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
930.85 938.94 1,059.47 1,132.83 1,457.84

Sheel Biotech Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets 930.85 938.94 1,059.47 1,132.83 1,457.84
NSE:SHEEL
18GF Score
Sheel Biotech Ltd NSE:SHEEL
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sheel Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sheel Biotech's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=1269.917+187.926
=1,458

Sheel Biotech's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=1269.917+187.926
=1,458

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of ₹1,458 Mil mean?
Sheel Biotech (NSE:SHEEL) has a Total Assets of ₹1,458 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Sheel Biotech and its competitors.
Is Sheel Biotech's Total Assets too high?
Sheel Biotech's current Total Assets is ₹1,458 Mil. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Total Assets compare to ADM and BG?
Sheel Biotech's Total Assets of ₹1,458 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Consumer Packaged Goods company?
A good Total Assets depends on the Consumer Packaged Goods industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Sheel Biotech and its competitors. Sheel Biotech's current Total Assets is ₹1,458 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Total Assets of ₹1,458 Mil. The current Total Assets is ₹1,458 Mil. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Total Assets is ₹1,458 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sheel Biotech Business Description

Address Guru Ravidas Marg, 8 Balaji Estates, 2nd Floor, Block-C, Kalkaji, South Delhi, New Delhi, IND, 110019
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score

Get the complete analysis for NSE:SHEEL

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.00
Price